DermDash: Vitiligo Spotlight: A Closer Look at JAK Inhibitors: An Online Actvity
Released on
December 3, 2025
Duration
15 minutes
Earn up to
0.25 AMA PRA Category 1 Credit™
This 15-minute DermDash highlights practical, real-world pearls for incorporating JAK inhibitors into the management of patients with vitiligo. Learners will review emerging data, patient selection considerations, and strategies to optimize long-term outcomes and durability of repigmentation in clinical practice.
FC25: Vitiligo Derm Dash: Exploring Treatment Advances and Optimizing Patient Care: An Online Activity
This activity is supported by an educational grant from Incyte.